<?xml version='1.0' encoding='UTF-8'?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/'><id>tag:blogger.com,1999:blog-28795933</id><updated>2008-08-14T09:46:37.410-04:00</updated><title type='text'>Bremelanotide Bulletin</title><link rel='alternate' type='text/html' href='http://www.bremolanotide.com/bremelanotide-bulletin/index.php'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default'/><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://www.bremolanotide.com/bremelanotide-bulletin/atom.xml'/><author><name>Editor</name><email>noreply@blogger.com</email></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>8</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-28795933.post-3725280452043788895</id><published>2008-05-20T11:33:00.009-04:00</published><updated>2008-07-24T12:05:15.225-04:00</updated><title type='text'>PL-6983 is the New Bremelanotide</title><summary type='text'>It's been quite a while - and quite a 'roller coaster ride' - since our last report on the Bremelanotide Bulletin.  There has been both good news and not so good news about the development of Bremelanotide, and you can check out the sections below to learn more about both it and other similar products and drugs currently being tested...

In this Edition, you can read about:
The Bremelanotide Time</summary><link rel='alternate' type='text/html' href='http://www.bremolanotide.com/bremelanotide-bulletin/2008/05/pl-6983-is-new-bremelanotide.php' title='PL-6983 is the New Bremelanotide'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=28795933&amp;postID=3725280452043788895' title='5 Comments'/><link rel='replies' type='application/atom+xml' href='http://www.bremolanotide.com/bremelanotide-bulletin/atom.xml' title='Post Comments'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/3725280452043788895'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/3725280452043788895'/><author><name>Editor</name><email>noreply@blogger.com</email></author></entry><entry><id>tag:blogger.com,1999:blog-28795933.post-99664621063534351</id><published>2007-03-30T06:53:00.001-04:00</published><updated>2008-05-12T12:43:45.137-04:00</updated><title type='text'>New Bremelanotide Results for Women and Video Link</title><summary type='text'>There have been a few new interesting developments in both the progress of Bremelanotide trials and some coverage by news outlets (including a video report).

Here's some of the latest information for you to check out...

- Phase IIa results for postmenopausal women (and more from premenopausal women too)
A Seattle ABC news affiliate has an article and video report about Bremelanotide and another</summary><link rel='alternate' type='text/html' href='http://www.bremolanotide.com/bremelanotide-bulletin/2007/03/new-bremelanotide-results-for-women-and.php' title='New Bremelanotide Results for Women and Video Link'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=28795933&amp;postID=99664621063534351' title='28 Comments'/><link rel='replies' type='application/atom+xml' href='http://www.bremolanotide.com/bremelanotide-bulletin/atom.xml' title='Post Comments'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/99664621063534351'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/99664621063534351'/><author><name>Editor</name><email>noreply@blogger.com</email></author></entry><entry><id>tag:blogger.com,1999:blog-28795933.post-116604164688273645</id><published>2006-12-13T15:14:00.000-05:00</published><updated>2007-02-23T11:16:57.209-05:00</updated><title type='text'>Bremelanotide Results for Men and Women</title><summary type='text'>Due to some file restructuring, I've created this page for a quick link to the most recent test results published for Bremelanotide...

UPDATE: Our next issue will be released within the week (before March 1)
Subscribe to our newsletter at the right to have updates emailed directly to your inbox.

Most recent: December 2006 Bremelanotide Bulletin Edition
Recap Results for Trials with Pre &amp; Post </summary><link rel='alternate' type='text/html' href='http://www.bremolanotide.com/bremelanotide-bulletin/2006/12/bremelanotide-results-for-men-and.php' title='Bremelanotide Results for Men and Women'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=28795933&amp;postID=116604164688273645' title='0 Comments'/><link rel='replies' type='application/atom+xml' href='http://www.bremolanotide.com/bremelanotide-bulletin/atom.xml' title='Post Comments'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/116604164688273645'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/116604164688273645'/><author><name>Editor</name><email>noreply@blogger.com</email></author></entry><entry><id>tag:blogger.com,1999:blog-28795933.post-116560420477590233</id><published>2006-12-08T13:42:00.000-05:00</published><updated>2006-12-15T13:36:29.243-05:00</updated><title type='text'>Bremelanotide Phase 2a Trial Results</title><summary type='text'>NOTE: Phase IIa Bremelanotide trial results conducted initially with pre-menopausal women with FSD (female sexual dysfunction) followed by post-menopausal women results published in August. Pre-menopausal test results are summarized below and a brief summary of post-menopausal group results can be found in the "Update" at the end of this post.

Phase IIb Bremelanotide trials were conducted with </summary><link rel='alternate' type='text/html' href='http://www.bremolanotide.com/bremelanotide-bulletin/2006/12/bremelanotide-phase-2a-trial-results.php' title='Bremelanotide Phase 2a Trial Results'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=28795933&amp;postID=116560420477590233' title='2 Comments'/><link rel='replies' type='application/atom+xml' href='http://www.bremolanotide.com/bremelanotide-bulletin/atom.xml' title='Post Comments'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/116560420477590233'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/116560420477590233'/><author><name>Editor</name><email>noreply@blogger.com</email></author></entry><entry><id>tag:blogger.com,1999:blog-28795933.post-116240781260265501</id><published>2006-11-01T14:03:00.001-05:00</published><updated>2008-05-12T12:44:59.786-04:00</updated><title type='text'>Bremelanotide Presentation at  Bio Investor Forum</title><summary type='text'>Carl Spana, CEO and President of Palatin Technologies, recently spoke at the Bio Investor Forum in San Francisco to provide some current news about Bremelanotide (breem-oh-LAN'-oh-tyd) along with other Palatin research projects.

Following is a summary of what was said about Bremelanotide during that presentation.

[Caveat: every attempt was made to transcribe the audio presentation accurately.  </summary><link rel='alternate' type='text/html' href='http://www.bremolanotide.com/bremelanotide-bulletin/2006/11/bremelanotide-presentation-at-bio.php' title='Bremelanotide Presentation at  Bio Investor Forum'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=28795933&amp;postID=116240781260265501' title='0 Comments'/><link rel='replies' type='application/atom+xml' href='http://www.bremolanotide.com/bremelanotide-bulletin/atom.xml' title='Post Comments'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/116240781260265501'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/116240781260265501'/><author><name>Editor</name><email>noreply@blogger.com</email></author></entry><entry><id>tag:blogger.com,1999:blog-28795933.post-115103598566061439</id><published>2006-06-22T20:41:00.001-04:00</published><updated>2008-05-12T12:45:52.662-04:00</updated><title type='text'>Palatin Technologies Release Phase IIb Bremelanotide Results</title><summary type='text'>There have been some very interesting Bremelanotide developments over the past month and, after digesting and absorbing all that data, here is a summary of the latest news...

Recap: Phase IIa Results (Pre and Post Menopausal Females)Summary: Phase IIb Results (Diabetic and Non-Diabetic Males)Palatin Technologies Presents at  9th European Society for Sexual Medicine Congress Bremelanotide </summary><link rel='alternate' type='text/html' href='http://www.bremolanotide.com/bremelanotide-bulletin/2006/06/palatin-technologies-release-phase-iib.php' title='Palatin Technologies Release Phase IIb Bremelanotide Results'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=28795933&amp;postID=115103598566061439' title='11 Comments'/><link rel='replies' type='application/atom+xml' href='http://www.bremolanotide.com/bremelanotide-bulletin/atom.xml' title='Post Comments'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/115103598566061439'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/115103598566061439'/><author><name>Editor</name><email>noreply@blogger.com</email></author></entry><entry><id>tag:blogger.com,1999:blog-28795933.post-114987657134498802</id><published>2006-06-09T13:42:00.002-04:00</published><updated>2008-04-28T13:48:51.347-04:00</updated><title type='text'>Bremelanotide at the International Sexologists Conference</title><summary type='text'>A recent article in the German online mag Spiegel.de discusses Palatin's presentation of Bremelanotide at a recent International Conference of Sexologists.

The writer follows a researcher who is developing another new drug to enhance sexual arousal and describes what happened when Palatin presented the results of Bremelanotide to the experts in that field.

The article follows George Dodd, a 63 </summary><link rel='alternate' type='text/html' href='http://www.bremolanotide.com/bremelanotide-bulletin/2006/06/bremelanotide-at-international.php' title='Bremelanotide at the International Sexologists Conference'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=28795933&amp;postID=114987657134498802' title='4 Comments'/><link rel='replies' type='application/atom+xml' href='http://www.bremolanotide.com/bremelanotide-bulletin/atom.xml' title='Post Comments'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/114987657134498802'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/114987657134498802'/><author><name>Editor</name><email>noreply@blogger.com</email></author></entry><entry><id>tag:blogger.com,1999:blog-28795933.post-114867039980884097</id><published>2006-05-26T13:27:00.000-04:00</published><updated>2006-06-22T20:35:04.333-04:00</updated><title type='text'>Bremelanotide's PT-141 Test Results</title><summary type='text'>While searching online for information about Bremelanotide, I stumbled upon an article featured last year on the New York Metro website.

It is a very thorough, five page compilation that discusses both the history of how this revolutionary product was discovered and reveals how it has affected early test subjects - both rodent and human.

Here's a summary of some of the more important parts of </summary><link rel='alternate' type='text/html' href='http://www.bremolanotide.com/bremelanotide-bulletin/2006/05/bremelanotides-pt-141-test-results.php' title='Bremelanotide&apos;s PT-141 Test Results'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=28795933&amp;postID=114867039980884097' title='4 Comments'/><link rel='replies' type='application/atom+xml' href='http://www.bremolanotide.com/bremelanotide-bulletin/atom.xml' title='Post Comments'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/114867039980884097'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28795933/posts/default/114867039980884097'/><author><name>Editor</name><email>noreply@blogger.com</email></author></entry></feed>